PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery

QIDP designation provides additional five years of market exclusivity and eligibility for FDA priority review and Fast Track designation. A Phase II clinical study in abdominal surgery is currently ongoing with more than 140 patients already enrolled, top-line results are expected in the second